Live Breaking News & Updates on Prnewswire Cantargia|Page 4

Stay updated with breaking news from Prnewswire cantargia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Cantargia reports first non-squamous NSCLC patient treated with nadunolimab, Keytruda® and chemotherapy

(Nasdaq: CANTA) (Stockholm: CANTA) today reported that the first patient has been treated in a new arm of. ....

Prnewswire Cantargia , Nasdaq Stockholm ,

Cantargia AB: Cantargia: Oral presentation of new preclinical CAN10 efficacy data in systemic sclerosis at ACR Convergence

LUND, Sweden, Sept. 15, 2022 /PRNewswire/ Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today reported new preclinical data demonstrating efficacy of its anti-inflammatory IL1RAP-binding ....

United States , Prnewswire Cantargia , Heinrich Heine University Hiller Research Center , Nasdaq Stockholm , Systemic Sclerosis , Related Disorders ,

Cantargia AB: Cantargia presents preclinical data demonstrating unique treatment effects of nadunolimab on pancreatic cancer stromal cells

LUND, Sweden, Sept. 14, 2022 /PRNewswire/ Cantargia (Cantargia AB) (NASDAQ Stockholm: CANTA) today reported preclinical data for its lead candidate, the IL1RAP-binding antibody nadunolimab ....

United States , Prnewswire Cantargia , Lund University , Pancreatic Cancer Action Network Pan , Pancreatic Cancer , Pancreatic Cancer Action Network ,

Cantargia AB: Cantargia publishes preclinical data on strong anti-tumor efficacy of nadunolimab in combination with chemotherapy

LUND, Sweden, Aug. 30, 2022 /PRNewswire/ Cantargia (Cantargia AB) (Nasdaq Stockholm: CANTA) today reported publication of preclinical results demonstrating that Cantargia's lead candidate ....

Rydberg Millrud , Prnewswire Cantargia , Nasdaq Stockholm , Cancer Immunology ,

Cantargia reports new positive preclinical efficacy data for CAN10 supporting development in myocarditis

LUND, Sweden, July 25, 2022 /PRNewswire/ Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today reported. ....

United States , Prnewswire Cantargia , Johns Hopkins University School Of Medicine , Cardiovascular Sciences , Nasdaq Stockholm , Johns Hopkins University School , Basic Cardiovascular Sciences , Scientific Sessions ,